Workflow
Lexicon Pharmaceuticals to Report Fourth Quarter 2025 Financial Results on March 5, 2026
Globenewswire· 2026-02-26 13:30
THE WOODLANDS, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its fourth quarter 2025 financial results on Thursday, March 5, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update. Participants can access the conference call live via webcast on the Events page of the Company’s website at http ...
Runway Growth Finance Corp. Announces First Quarter 2026 Dividend of $0.33 per Share
Globenewswire· 2026-02-26 13:30
MENLO PARK, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that its Board of Directors has declared a first quarter 2026 cash distribution of $0.33 per share. The following shows the key dates of the first quarter 2026 dividend: Declaration Date: February 25, 2026Record Date: March 10, 2026Paym ...
DeFi Development Corp. Announces Investment in Apyx, The First Dividend-Backed Stablecoin (DBS) Protocol
Globenewswire· 2026-02-26 13:30
BOCA RATON, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first public company with a treasury strategy designed to accumulate and compound Solana (“SOL”), today announced a strategic investment in Apyx, a Dividend-Backed Stablecoin (DBS) protocol. DFDV participated as the first institutional capital in the project, establishing an early position in the emerging DBS category. Apyx is designed to source yield from preferred equity issued by Digital Asset Tre ...
Global Mofy AI Limited (GMM.US)'s Mofy VFX Powers iQIYI Mist Theatre Crime Series Hit Justice in the Shadows with Visual Effects Production
Globenewswire· 2026-02-26 13:30
BEIJING, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets, today announced that its visual effects brand, Mofy VFX, provided visual effects (“VFX”) production services for the 16-episode crime drama series Justice in the Shadows. The series, adapted from Lei Mi’s novel Old Boy and directed by Teng Huatao, is produced by iQ ...
Champion Safe Continues to Build Sales Momentum as Sports Inc. Dealers Shift to Enhanced Challenger 20 Safe Model
Globenewswire· 2026-02-26 13:30
American Rebel Holdings Inc Champion Safe Continues to Build Sales Momentum as Sports Inc. Dealers Shift to Enhanced Challenger 20 Safe Model American Rebel Holdings Inc Champion showcased its Trophy Series Independent retailers place spring orders in Phoenix as Challenger 20 replaces the Sports Inc–exclusive Model T with an integrated 120V outlet and refreshed black-chrome hardware—built with American-made steel Provo, UT, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Champion Safe Company (championsafe.com), ...
PennantPark Floating Rate Capital Ltd. Prices Public Offering of $200 Million 6.75% Notes
Globenewswire· 2026-02-26 13:28
MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the “Company”) (NYSE: PFLT) today announced that it has priced an underwritten public offering of $200 million aggregate principal amount of its 6.75% notes due 2029 (the “Notes”). The Notes will mature on March 4, 2029 and may be redeemed in whole or in part at the Company’s option at any time at par plus a “make-whole” premium, if applicable, provided that the Notes may be redeemed at par three months prior to their maturity. ...
Primech Holdings Secures Approximately US$5.02 Million in Multi-Year Residential Cleaning Contracts, Expanding Recurring Revenue Base
Globenewswire· 2026-02-26 13:27
Strengthening Recurring Revenue Base Through Multiple Multi-Year Residential Contract Awards.SINGAPORE, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Primech Holdings Limited (Nasdaq: PMEC), an established technology-driven facility services provider servicing public and private sectors primarily in Singapore, today announced that its subsidiary Primech A & P Pte. Ltd. (“Primech A & P”) has successfully secured a series of new residential cleaning and waste management service contracts with a total estimated value of a ...
PharmAla Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia
Globenewswire· 2026-02-26 13:26
TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), announced that it has executed an agreement with Spaulding Rehabilitation (“Spaulding Rehabilitation”), a member of the Mass General Brigham healthcare system, for the provision of MDMA for use in a clinical trial investigating MDMA-assisted therapy for the trea ...
STEALTHGAS INC. Announces the Date for the Release of the Fourth Quarter and Twelve Months 2025 Financial and Operating Results, Conference Call and Webcast
Globenewswire· 2026-02-26 13:24
ATHENS, Greece, Feb. 26, 2026 (GLOBE NEWSWIRE) -- STEALTHGAS INC. (NASDAQ: GASS) (the “Company”), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today that it will release its fourth quarter operating and financial results for the period ended December 31, 2025 before the market opens in New York on March 2, 2026. On March 2, 2026 at 10:00 am ET, the company’s management will host a conference call to discuss the results and the compa ...
SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247
Globenewswire· 2026-02-26 13:23
Results from IV Phase 1 SAD/MAD Trial Expected in 2026JERSEY CITY, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the first participants have been dosed in a Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) trial evaluating the intravenous formulation (IV) of its second-generation triterpenoid antifungal therapy, S ...